AIMS is pleased to provide a forum for fresh perspectives on the Canadian public health care system. AIMS Health Policy Fellow David Zitner and AIMS Board Director George Cooper offer their points of view on what can be done to fix a system in need.
This paper examines the degree to which provincial drug plans reflect the results of the Common Drug Review, ultimately finding that the review has NOT resulted in consistent availability to pharmaceuticals across the provinces.
Health care reform has become a major policy issue in the United States as US President Barack Obama promotes significant reform. This article, co-authored by AIMS Founding President Brian Lee Crowley, appeared on the Reuters wire service. It explains that the experience in Canada and France shows that government health insurance and government financing lead to a crackdown on health care providers and bureaucratization of the entire health care system.
This paper examines the practice of "Reference Pricing". Basically it’s a method used to control spending on prescription drugs by public and private insurance systems. Under this approach, drugs which are judged to be interchangeable are classified in therapeutic classes, and a reimbursement ceiling is set up for the whole class.
In this op-ed that appeared in the Providence Journal, AIMS President Brian Lee Crowley explains why drug re-importation from Canada will not solve the problem of rising prescription drug costs in the United States. He reminds Americans how the US legal system imposes a huge tax on health care that Canadians do not have to pay.
In this op-ed that appeared in the Buffalo News, AIMS President Brian Lee Crowley explains why drug re-importation from Canada will not solve the problem of rising prescription drug costs in the United States.